ARTL

Artelo Biosciences, Inc. (ARTL)

NASDAQ
$0,70
$-0,01
(-1,68%)
Artelo Biosciences, Inc. (ARTL) Live Price Chart
Last updated: ⁦2026-08-26 14:46:00⁩. Stock price data is sourced from Massive.

Key Market Data

$3,17M

$0,71

$39 031,20

$0,66

$0,72

$-0,01

-1,68%

19K

Artelo Biosciences, Inc. (ARTL) Stock Price Today

Artelo Biosciences, Inc. (ARTL) is currently trading at $0,70 as of 2026-08-26 14:43:00, reflecting a -1,68% move ($-0,01) from the previous close.

In the short term, the stock has returned -20,35% over the past four weeks. Over the last 12 months, Artelo Biosciences, Inc. has recorded a -97,41% price change, indicating a Weak performance relative to the broader market.

Artelo Biosciences, Inc. (ARTL) 7-Day Stock Price Changes

Over the past seven days, Artelo Biosciences, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $0,72 to the latest recorded price of $0,70, reflecting an intraday change of -1,68%. Daily movements highlight shifts in trading volume (18 500), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, ARTL has delivered a -20,35% return over the past month and a -97,41% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Artelo Biosciences, Inc. (ARTL)

You can buy and trade ARTL on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for ARTL and Execute Your Trade
Step 3: Search for ARTL and Execute Your Trade
Open the trading page, enter ARTL in the search bar, select the amount of ARTL you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Artelo Biosciences, Inc. (ARTL)?

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Artelo Biosciences, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
7
Sector
PHARMACEUTICAL PREPARATIONS
Company Website

Frequently Asked Questions (FAQ)

1.Can I buy and sell U.S. stocks directly on MEXC right now?
Yes. MEXC supports direct trading of U.S. stocks in three ways: RealStocks (held via a regulated broker partner), Tokenised Stocks that trade 24/7 with self-custody, and Stock Futures with up to 200x leverage. You can fund a purchase with local currency or crypto, and manage all three product types from a single account.
2.What type of U.S. stocks can I trade on MEXC?
You can trade thousands of leading U.S. equities listed on major exchanges like the NYSE and NASDAQ, including tech giants like Apple (AAPL), Tesla (TSLA), and NVIDIA (NVDA), as well as newly listed IPOs. Availability varies by product type — RealStocks, Tokenised Stocks, and Stock Futures each carry their own list of supported tickers.
3.Are stock prices and trading data updated in real-time?
Yes. MEXC provides real-time pricing, 24-hour fluctuations, and market cap rankings across all three stock products, so your buy and sell decisions are based on live data, not delayed quotes.
4.Can I trade U.S. shares 24/7, or only during market hours?
It depends on the product. RealStocks follow standard U.S. market hours (9:30 AM–4:00 PM ET, Monday–Friday). Tokenised Stocks and Stock Futures trade continuously, 24/7, letting you act on price moves even when traditional markets are closed.
5.Does MEXC charge commission on U.S. stock trading?
RealStocks trade commission-free. Tokenised Stocks and Stock Futures carry a small trading fee, among the lowest in the industry — currently as low as 0.00%/0.02% maker/taker on Stock Futures.
6.What does ARTL's EPS tell investors about its profitability?
Trailing-twelve-month EPS of $ -2,76 summarises how much profit Artelo Biosciences, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track Artelo Biosciences, Inc.'s financial performance over time?
To follow Artelo Biosciences, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how ARTL is performing and how the market is responding.
8.When is Artelo Biosciences, Inc. expected to report earnings?
Artelo Biosciences, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for ARTL, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in Artelo Biosciences, Inc.'s earnings reports?
Artelo Biosciences, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether ARTL is meeting, beating or missing expectations.
10.How can I stay informed about Artelo Biosciences, Inc.'s results and guidance?
You can stay up to date on Artelo Biosciences, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for ARTL on this page helps you see how new information is being reflected in the stock.
11.Does Artelo Biosciences, Inc. pay a regular cash dividend to its shareholders?
Artelo Biosciences, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor ARTL's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for ARTL?
Based on the latest earnings data, ARTL has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Artelo Biosciences, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Artelo Biosciences, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is Artelo Biosciences, Inc.?
Artelo Biosciences, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is ARTL valued in terms of P/E ratio and EPS?
Artelo Biosciences, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -2,76. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Artelo Biosciences, Inc.'s earnings. Comparing ARTL's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

MEXC Aug 8: Share $500KMEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

ARTL-to-USD Calculator

Amount

ARTL
ARTL
USD
USD

1 ARTL = 0,701 USD